Vorsitz/Chair: Oliver Dörr (Frankfurt am Main), Hans-Josef Feistritzer (Leipzig)
Agenda
(P1279)
Patientenadhärenz in der lipidsenkenden Therapie: verlorener Posten oder Chance zur Verbesserung?
V. Schettler (Göttingen)
Zum Abstract
(P1280)
Optimization of Pre-Test Probability Assessment in Suspected Chronic Coronary Syndrome: Integrating Established Cardiovascular Biomarkers with 2024 ESC Guidelines - A Large-Scale Prospective Analysis
A. Teren (Bielefeld)
Zum Abstract
(P1281)
Drug-Coated Balloons versus Second-Generation Drug-Eluting Stents for In-Stent Restenosis: Insights from Real-World Data
J. Krefting (München)
Zum Abstract
(P1282)
Das individuelle Bildungsniveau beeinflusst die Anbindung an einen niedergelassenen Kardiologen nach akutem Myokardinfarkt
D. Füller (Brandenburg an der Havel)
Zum Abstract
(P1283)
Socioeconomic Status Strongly Predicts Risk Factors for Myocardial Infarction and Long-Term Prognosis
H. Kerniss (Bremen)
Zum Abstract
(P1284)
Comparison of 2019 vs. 2024 ESC guidelines for the assessment of pre-test probability of coronary artery disease in a German prospective real-world cohort – The ECAD II study
V. Backmann (Essen)
Zum Abstract
(P1285)
In-Hospital and One-Year Outcomes after Percutaneous Coronary Intervention for chronic coronary occlusion in Octogenarians